Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Industry
>>
Simcere collaborates with BMS to develop cardiovascular compound
>> article
Simcere collaborates with BMS to develop cardiovascular compound
Editor:bianch Clicks:
0
Date:2011-12-15 10:22:12
Keyword:
Simcere BMS
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Merck and Simcere launch JV in China
BMS aims drugs for chronic diseases in China
Simcere RA medication gets approval
Merck and Simcere signed agreement to establish JV in China
Celgen gets new drug approval for Qiangke
Simcere obtains right of BMS-817378 in China
Simcere and BMS partner to develop oncology compound
Simcere acquires additional satke in Boda
Simcere Pharma make response to vaccines event
Simcere completes Endostar phase IV study
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
